Oramed Pharmaceuticals Inc. To Present At The GTC Diabetes Summit
JERUSALEM, April 20, 2015 /PRNewswire/ --
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the company will participate in the upcoming Annual GTC Diabetes Summit, in the 8th Diabetes Drug Discovery & Development Conference, taking place April 27-29, 2015 in Boston. Dr. Miriam Kidron, Oramed's Chief Scientific Officer, will present a session titled "Early Clinical Impressions of Oral Insulin in Type 1 Diabetes Patients" on April 28, 2015.
Help employers find you! Check out all the jobs and post your resume.
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the company will participate in the upcoming Annual GTC Diabetes Summit, in the 8th Diabetes Drug Discovery & Development Conference, taking place April 27-29, 2015 in Boston. Dr. Miriam Kidron, Oramed's Chief Scientific Officer, will present a session titled "Early Clinical Impressions of Oral Insulin in Type 1 Diabetes Patients" on April 28, 2015.
Help employers find you! Check out all the jobs and post your resume.